Sagefield Capital’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
Sagefield Capital's TSVT Position: Q2 2025 in Review
Sagefield Capital sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 115,889 shares — an estimated $572K sold.
Sagefield Capital first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $572K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.
- Sagefield Capital reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
- Sagefield Capital sold 115,889 2seventy bio shares in Q2 2025, an estimated $572K.
- Sagefield Capital first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
- Sagefield Capital's 2seventy bio position peaked at $572K in Q1 2025.
- 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.
Based on Sagefield Capital's 13F filing for Q2 2025, filed 14 Aug 2025.